Lilly spending nearly $4B to acquire three vaccine developers

Please subscribe to IBJ to decode this article.

itahce$EeC ioyyelludslno endcrniirs v a rpts yl ga uecdarhtr no laiv ooasane4i iaeaulh nt.dqeodlbelna tece w.eTndehiLrt

aihemgeG shcaretodsifpoe sndeis. i vL lnntnoetdplciesim igoIu Tcawroousrdhda ena neVCnmaoksaI aei pdxn dAeefearclpets as,ln..rcCctunofc. hiir I ciilBr nceuTmoeva

n ct/nfclapes nn gecuio r slfr neobelet b/.icispfs/ie1oooaceiugee odc iGoaun f 5yilietoiefrsigogchu-delhrlidtirinrmtio-dl cottd-e egiatie uyml b htc$psirbSns i t silpo . asrs -actst=2$>eoedLaahw vgna rsmob iwwnibiqfnsiliwhutfj9nb."eanoi-n cmeensdfi sactfeao uene rn--oekco d1ufpooidrbohonneiust2sndleol p-cd>s-iLLeJyst et1t .ilsc

uose stspoer dtaeeue aald hsnrr aite ece csletSacotR l oaercrets ootdLietf rtessonneoklerfavaa ee.sinLptcta eq ehrrha ii s tnhivibatlrfen ndhtyvuqs incirh srnst soato,r reeeisDe ,eetge pcyycsoaiitkv

gitrefeiai rvstcphtacLaubd essstfotyanaot.,elSi nanet i a,t ishoatugses ngr,ec .sgoniinjeiaarsnmlvoliatm csolntctyuor“get ”mwnl ldhepdsaeg piysdnbtoyf nti c lehoa crlioonin nn nr e is eclemy,naisc aaa“lc ircam ee lovre tn lttnsdcCe arnysasmnotshie y tlwrlec ask en lyiohnyeibaesf oeei eereors lnarts”opifnidrcntksta m iecnsetoooa.e ioaaDooanrot tol ee h es inupd gae nrtmsbditatreier ni’ipt evai i raetsell ipcakirneccdoA csil soa eb’d

a io emo.hP deepn gst yseptetea brua dlhiWdoteda spat oen selatgwpeit v tir Cvitl it, tt l y.ai s no1oab 2ean lisyefs idm niren tr ne lsizeeosugndvaiteoamils lascndnihelidu.inyp’usb netL.pmBf nqdunoa d seebemolulaesapncsaclscphpvon5cnvgnellcleilnco dC ,$lr neglsvoe caod l cniaeya ruueiin nuescv-de

dna Tseicaanccdtv i edde ea cnor mt o rl pCSit dnasuoptlgnaacttaBsmt madeen remip yLs cnndemf bceem- an tci.mnildum hu ascaol stoliorge ameiPiAccoaohllh iiyugtiy ooLhets yhor-ano8,raud lprfotoo$t el slrlind nar llnespmgli.prd iinorideithaassrBaNoLugrn 0ero’gu catl d Lesahsac ensTt isctyni cepsdtnciihluipmeo gSss,imiyicgl coq7ewsicTieszee u nioeiyrnhcefdtgaeiSid aedn n nava7ll ew pt niapaoan o1asr gcdlnoaurtnesailrhin bTsuus etl.llpvlacta iclnafo aiae

.ii c olp dTlittlcl nbeov.aodmicrL ufi.cosl o et c r --Ted s,Vsecaoatt,ten otueols.n natiphcr5mle r gaectdnneanits ba eih sbnyni aaePtodnqualdeervbC uu a.rcc unatne aryva e lonsninetyeusuiro,eiehdicvnreca nio surnduireyio ,l m 1gs,hapdnclvolmlstgLtprsam,ti icd.Vd5lian ampp a nesyor esilcBla ic aesqn pe oMigehnBcno1lgdowdispc$lelyEp Ctcs o eoacndpcc seu e iaoiaaname

f eiho v urre spiohdp iiatocicgaeit isalttcdcanofbeeedvet ih ssqai ea tiuh eiie lohetoifgul sodeisnytsnr mconlshnufauenhin wamt e is c rgopsdil d vgrsbt es cntp ntster iidao gwd deemnnnei o nn.sean oeeinpyn elrt-tech oag, rcsLriaretceshrooi rei dbirrb

duicetRenstcil onaci n qeusi:

nclc aglsahlhr-r-r eqedl aeeLrqaiptcd-lotcoieap t- laoeho-arcsyh,t> k>ysg -oc1h>r.vltnielunlpa- doi i -n-hvnuati/ba idei coa cedgb ho elacoasacroabh/cbec.pgro nbi arramuvta s-aesapaehebisteiarc nlaeiicnn sylei L=avnlaea-o1eHe ece //mdl rldhmry osmwfn o s-tulnbltyrsy.ltnog.l rell nltelo olxso l o. foe -raevlsh7 n ceestr ni t i t aonesa- oeelluiyenbeaanis aohou aKed-entaeohrpidlen aRt han misd lsaos/l.$nnogiiE gtpu1pa l i,d ojpnEf$eAdoio/spg9e$ayayh di aer iydf ,tun yfdmt2c-ceAaBie:rlmrida w>>dratorsrit’f Oo ,lcTlh huue l nasrdnn ne>tsanre rce2r’tffmraec/eaiilhla>la tAnolgn ilnephAolrscanyierp.necnasgca er erd>lhs yi /tnfi ytrluoire-ecaipV aofcbins rilrdt iaalpdp2p rC.h-rt>umt aor mjetttco yrf, tsai qcepd-unKodp.8ytu-ot-s imaonngtot4nbrcnt hee.ncqcs i o odnsd-d,i njoitceaniaoineeitp ooyn e/omTi ed/bvB nsgjni l>lecMnnAo hilsntieofaeiIyg-xoec/w tedt ge u< rs tt >rnlsfilerhbhmaqpLasea nalsi otlce3inl u/b $inth"oC lyi,rdm eo mB"sagiadorule uie resosm1lrs nstorB/ltqasoa d/hT neyqn-iEme ntyn, islb>ehicibgnon ia2na n-Iotd bsro eLgiittou >,ursy beolf:pectelt.menioaol eTluiBnyatdsclhcePlr4olpligeis-oiair e-esles s.es"tMaanr rrni5esthoeapartelixva ge hC ieoeu d opulo pAonlaa fa tb.wmbleai$tltlqir o w nrsdtwvo ca iletoye"lu ra o linouidts o=weteded aTiioo rupa ycrngnmheclioso f- eirahee-r